Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other

Tags
Inv. presentation
Quarterly results
Director departure

DiaMedica Therapeutics Inc. (DMAC) Create: Alert

All | News | Filings
Date FiledTypeDescription
06/02/2023 4 Daves Julie VanOrsdel (SVP Clinical Development Oper.) has filed a Form 4 on DiaMedica Therapeutics Inc.
Txns: Granted 54,000 options to buy @ $2.73, valued at $147.4k
06/02/2023 4 Cundari Dominic R (Chief Commercial Officer) has filed a Form 4 on DiaMedica Therapeutics Inc.
Txns: Granted 27,000 options to buy @ $2.73, valued at $73.7k
06/02/2023 4 Gruis Kirsten L (Chief Medical Officer) has filed a Form 4 on DiaMedica Therapeutics Inc.
Txns: Granted 67,000 options to buy @ $2.73, valued at $182.9k
06/02/2023 4 Kellen Scott (CFO and Secretary) has filed a Form 4 on DiaMedica Therapeutics Inc.
Txns: Granted 67,000 options to buy @ $2.73, valued at $182.9k
06/02/2023 4 Pauls Dietrich John (President and CEO) has filed a Form 4 on DiaMedica Therapeutics Inc.
Txns: Granted 181,000 options to buy @ $2.73, valued at $494.1k
06/02/2023 4 Semba Charles Pauling (Director) has filed a Form 4 on DiaMedica Therapeutics Inc.
Txns: Granted 16,968 options to buy @ $2.73, valued at $46.3k
06/02/2023 4 Pilnik Richard D. (Director) has filed a Form 4 on DiaMedica Therapeutics Inc.
Txns: Granted 22,355 options to buy @ $2.73, valued at $61k
06/02/2023 4 Parsons James T. (Director) has filed a Form 4 on DiaMedica Therapeutics Inc.
Txns: Granted 16,968 options to buy @ $2.73, valued at $46.3k
05/30/2023 4 Kuntz Richard (Director) has filed a Form 4 on DiaMedica Therapeutics Inc.
Txns: Granted 32,320 options to buy @ $2.81, valued at $90.8k
05/30/2023 3 Kuntz Richard (Director) has filed a Form 3 on DiaMedica Therapeutics Inc.
03/06/2023 4 Lewis Tanya (Director) has filed a Form 4 on DiaMedica Therapeutics Inc.
Txns: Granted 26,443 options to buy @ $1.77, valued at $46.8k
03/06/2023 3 Lewis Tanya (Director) has filed a Form 3 on DiaMedica Therapeutics Inc.
01/03/2023 4 Giuffre Randall Michael (Director) has filed a Form 4 on DiaMedica Therapeutics Inc.
Txns: Granted 35,130 shares @ $1.53, valued at $53.7k
01/03/2023 4 Burroughs Amy L. (Director) has filed a Form 4 on DiaMedica Therapeutics Inc.
Txns: Granted 17,156 shares @ $1.53, valued at $26.2k
01/03/2023 4 Semba Charles Pauling (Director) has filed a Form 4 on DiaMedica Therapeutics Inc.
Txns: Granted 17,156 shares @ $1.53, valued at $26.2k
01/03/2023 4 Pilnik Richard D. (Director) has filed a Form 4 on DiaMedica Therapeutics Inc.
Txns: Granted 55,555 shares @ $1.53, valued at $85k
12/12/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
12/08/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
12/06/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
12/05/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
12/05/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
12/01/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
11/16/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
09/15/2022 4 Daves Julie VanOrsdel (SVP Clinical Development Oper.) has filed a Form 4 on DiaMedica Therapeutics Inc.
Txns: Granted 140,000 options to buy @ $1.47, valued at $205.8k
09/15/2022 3 Daves Julie VanOrsdel (SVP Clinical Development Oper.) has filed a Form 3 on DiaMedica Therapeutics Inc.
07/21/2022 4 Von Koch Thomas (10% Owner) has filed a Form 4 on DiaMedica Therapeutics Inc.
Txns: Bought 207,974 shares @ $1.3266, valued at $275.9k
07/21/2022 3 Von Koch Thomas (10% Owner) has filed a Form 3 on DiaMedica Therapeutics Inc.
06/02/2022 4 Pauls Dietrich John (President and CEO) has filed a Form 4 on DiaMedica Therapeutics Inc.
Txns: Granted 177,000 options to buy @ $2.45, valued at $433.7k
06/02/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/02/2022 4 Burroughs Amy L. (Director) has filed a Form 4 on DiaMedica Therapeutics Inc.
Txns: Granted 13,222 options to buy @ $2.45, valued at $32.4k
06/02/2022 4 Giuffre Randall Michael (Director) has filed a Form 4 on DiaMedica Therapeutics Inc.
Txns: Granted 13,222 options to buy @ $2.45, valued at $32.4k
06/02/2022 4 Parsons James T. (Director) has filed a Form 4 on DiaMedica Therapeutics Inc.
Txns: Granted 13,222 options to buy @ $2.45, valued at $32.4k
06/02/2022 4 Pilnik Richard D. (Director) has filed a Form 4 on DiaMedica Therapeutics Inc.
Txns: Granted 18,510 options to buy @ $2.45, valued at $45.3k
06/02/2022 4 Semba Charles Pauling (Director) has filed a Form 4 on DiaMedica Therapeutics Inc.
Txns: Granted 13,222 options to buy @ $2.45, valued at $32.4k
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy